Cingulate Inc. (CINGW)Kansas City, United States | NasdaqCM
0.03 USD
+0.01
(30.667%)
⇧
(April 21, 2026, 9:34 a.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:53 a.m. EDT
Severe fundamental distress indicated by massive losses, unsustainable debt, and recent executive legal issues; the price data shows erratic volatility with a sharp decline to $0.02, reflecting a high probability of bankruptcy or dilution via the reported ATP sales. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 350.214 |
| Beta | -0.77 |
| Website | https://www.cingulate.com |
| Attribute | Value |
|---|---|
| Address1 | 1,901 West 47th Place |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -0.765 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.346 |
| City | Kansas City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0294 |
| Current Ratio | 1.164 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0294 |
| Day Low | 0.0212 |
| Debt To Equity | 350.214 |
| Display Name | Cingulate |
| Ebitda | -19,397,214 |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -1.732 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0294 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0212 |
| Fifty Two Week Low Change | 0.008200001 |
| Fifty Two Week Low Change Percent | 0.3867925 |
| Fifty Two Week Range | 0.0212 - 0.0294 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 11,292,081 |
| Free Cashflow | -10,425,198 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 14 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -9,774,057 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-12-08 |
| Language | en-US |
| Long Business Summary | Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas. |
| Long Name | Cingulate Inc. |
| Market | us_market |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_1674914781 |
| Net Income To Common | -22,449,912 |
| Open | 0.0385 |
| Operating Cashflow | -17,245,182 |
| Operating Margins | 0.0 |
| Phone | 913 942 2300 |
| Previous Close | 0.0225 |
| Price Hint | 4 |
| Price To Book | 0.0849711 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.064 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0068999995 |
| Regular Market Change Percent | 30.666662 |
| Regular Market Day High | 0.0294 |
| Regular Market Day Low | 0.0212 |
| Regular Market Day Range | 0.0212 - 0.0294 |
| Regular Market Open | 0.0385 |
| Regular Market Previous Close | 0.0225 |
| Regular Market Price | 0.0294 |
| Regular Market Time | 1,776,778,486 |
| Regular Market Volume | 29,628 |
| Return On Assets | -0.83248 |
| Return On Equity | -4.50602 |
| Sand P52 Week Change | 0.34445214 |
| Sector | |
| Sector Key | |
| Short Name | Cingulate Inc. Warrants |
| Source Interval | 15 |
| State | KS |
| Symbol | CINGW |
| Total Cash | 10,953,383 |
| Total Cash Per Share | 0.942 |
| Total Debt | 8,786,555 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.732 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 29,628 |
| Website | https://www.cingulate.com |
| Zip | 66,205 |